## KKR: KKR & Co. Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 -1.9% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($121.41)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 7, Bearish: 0)

**1. KKR & Co. (KKR) Announces Income from Monetization Activity**
- Source: Finviz | 20251231T182407 | Bullish | Relevance: 100%
- KKR & Co. Inc. (NYSE: KKR) announced over $525 million in income from monetization activity between October 1 and December 19, 2025, primarily driven by realized performance income and strategic hedge fund partnerships. The company also released its 2026 global macro outlook, forecasting strong GDP and earnings growth due to low oil prices, increased savings, and accommodative financial conditions, while reducing China's inflation forecast. KKR, a private equity and real estate investment firm, anticipates continued technology-driven productivity gains and opportunities for private and public capital due to underinvestment in worker retraining.

**2. Brookfield closes $700 mn sale of Korean logistics center to KKR**
- Source: KED Global | 20251231T054309 | Bullish | Relevance: 100%
- Brookfield has completed the sale of a large logistics center near Seoul to KKR & Co. for approximately 1 trillion won ($700 million), marking the largest single-asset logistics transaction in South Korea to date. This deal follows a significant slowdown in approvals for new warehouse construction in the country in 2025.

**3. KKR Bid to Take Yomeishu Private Is Derailed By Top Shareholder**
- Source: Bloomberg.com | 20251231T040822 | Somewhat-Bearish | Relevance: 100%
- KKR & Co.'s attempt to take Japanese herbal tonic maker Yomeishu Seizo Co. private has been thwarted. Yomeishu terminated exclusive talks with KKR because its top shareholder, Yuzawa KK, does not intend to sell its stake, making the buyout proposal unfeasible. This decision came shortly after Yomeishu confirmed KKR had been granted first negotiating rights.

**4. KKR gets first negotiation rights to take Yomeishu private**
- Source: The Japan Times | 20251230T060805 | Bullish | Relevance: 100%
- U.S. investment firm KKR has secured first negotiation rights to acquire Yomeishu Seizo, a Japanese herbal health tonic manufacturer, marking a significant step in Japan's brisk corporate deal-making year. KKR intends to finalize terms, including the purchase price, and initiate a tender offer for Yomeishu in January. Yomeishu's shares surged by 14% following the news, increasing its market value by approximately Â¥11.3 billion.

**5. KKR Acquires Cheongna Logistics Center**
- Source: Business Wire | 20251230T040832 | Bullish | Relevance: 100%
- KKR, along with its affiliated Korean asset manager Kreate Asset Management, has completed the acquisition of Cheongna Logistics Center in Incheon, South Korea. This transaction marks the largest single asset logistics deal in Korea to date. Kreate will manage and operate the 4.6-million square feet facility, while KKR will support value creation strategies.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | Barclays | $169 | $154 | +10% |
| 2025-12-11 | UBS | $176 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | Barclays | main | Overweight |
| 2025-12-11 | UBS | init | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 14 ($2.87M) |
| Sells | 2 ($424.39M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 31.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 6.7% (+1.0%)
- Blackrock Inc.: 5.4% (-1.1%)
- Capital Internationa: 3.5% (-1.4%)
- State Street Corpora: 3.1% (+1.6%)
- Wellington Managemen: 2.7% (+1.3%)

### Key Risks

1. High beta (2.00) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Heavy insider selling: $424M sold (2 transactions in 90 days).
3. Market regime shift could impact high-beta names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.53 indicates undervaluation relative to growth. Forward P/E 18.8x attractive for 32% earnings growth. Balance sheet: strong liquidity (4.2x), $2.4B free cash flow. Revenue growth strong at 29% YoY. Analyst sentiment positive (1 raises, avg +10%). Insider selling cluster ($424.4M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $118.0B |
| Beta | 2.00 |
| 52W Range | $86.15 - $170.40 |
| Short Interest | 1.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.53 |
| Forward P/E | 18.8 |
| Current P/E | 24.8 |
| YoY Growth | 32.2% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -3.6% to -1.9% (+1.7% in 5 days), confirming momentum buildup. Below STRENGTH zone by 4.9pp (needs >3.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.00x) but short-term weakness (below SMA20). MACD histogram bearish (-1.02), momentum weakening. RSI neutral at 46. OFD pattern: -MUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.87% (CS: 14) | Neutral |
| RSI_14 | 45.9 | Neutral |
| MACD Histogram | -1.02 | Bearish |
| vs SMA20 | 0.964x | Below |
| vs SMA50 | 1.022x | Above |
| vs SMA200 | 1.001x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $127.47
- **Stop Loss:** $121.41 (4.8% risk)
- **Target:** $133.53 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 148
- **Position Value:** $18,865.56
- **Portfolio %:** 18.87%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with mixed signals requiring caution. VIX at 14.95 suggests calm markets, but record repo borrowing and narrowing breadth (51.4%) indicate stress beneath the surface. Positive yield curve (+62bps) and stable economic data support risk assets, but year-end dynamics mask true liquidity conditions.*

### Earnings

**Next:** 2026-02-06 (Est: $1.40)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.30 | $1.41 | +8.6% |
| 2025Q2 | $1.14 | $1.18 | +3.6% |
| 2025Q1 | $1.13 | $1.15 | +1.7% |
| 2024Q4 | $1.28 | $1.32 | +3.5% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*